Dr. Jeffrey R. Gruen, MD, FAAP

Associate Professor, Yale Child Health Research Center
Departments of Pediatrics, Genetics, and Investigative Medicine
Yale School of Medicine

polar_mountains-wideDr. Gruen has received continuous funding from the NIH for dyslexia research since 1999. He currently has an NIH grant to develop a pre-symptomatic genetic screening panel for identifying children at risk for developing reading disability, utilizing the Avon Longitudinal Study of Parents and Children (ALSPAC), a sample of over 10,000 children collected in the Avon region of the UK. In the 2005 annual breakthrough edition of the journal Science, the discovery of DCDC2 for dyslexia headed by Dr. Gruen, was named the 5th most important breakthrough of the year. In 2009, Dr. Gruen received a generous grant from the Manton Foundation to study genetics and dyslexia in minority children. This study, the GRaD Study (Genes, Reading and Dyslexia) is currently enrolling children ages 8-15 with and without reading problems.


Recent Presentations:

Dyslexia Videocast

Joan Bosson-Heenan

Associate Director
Yale School of Medicine
Department of Pediatrics

Joan brings considerable experience in managing clinical trials here at Yale University. Joan spent four years as Project Director for the CT Early Development Project (CEDP), an epidemiological study of child development in a longitudinal birth cohort of over 1300 children. She has also worked as a study coordinator for both the Yale Cancer Center and the Department of Pediatrics in Endocrinology, specifically Type I diabetes. Her combination of experience in both epidemiological and medical research makes her uniquely qualified to coordinate this multi-site project.


203.785.2376 (office)
203.464.1535 (cell)
203.737.5972 (fax)